A phase 1 clinical trial of sequential pralatrexate followed by a 48-hour infusion of 5-fluorouracil given every other week in adult patients with solid tumors

Jean L. Grem, Mary E. Kos, Ruby E. Evande, Jane L. Meza, James K. Schwarz

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Fingerprint Dive into the research topics of 'A phase 1 clinical trial of sequential pralatrexate followed by a 48-hour infusion of 5-fluorouracil given every other week in adult patients with solid tumors'. Together they form a unique fingerprint.

Medicine & Life Sciences